Anticoagulant therapy is underused in high-risk atrial fibrillation
Atrial Fibrillation Friday, September 27th, 2013MNT: Sept. 26, 2013
AMSTERDAM – Investigators are reporting widespread underuse of anticoagulant therapy in patients with atrial fibrillation (AF) who are at high risk of stroke, despite the fact that such therapy is known to decrease stroke risk in this population.
The findings were released at the European Society of Cardiology (ESC) Congress 2013 and represent one-year outcomes from the ongoing Global Anticoagulant Registry in the Field (GARFIELD), which is the largest prospective database tracking AF patients at increased stroke risk. Read More
